The PPARα–leukotriene B4 pathway to inflammation control
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Inflammation is a local immune response to 'foreign' molecules, infection and injury. Leukotriene B4, a potent chemotactic agent that initiates, coordinates, sustains and amplifies the inflammatory response, is shown to be an activating ligand for the transcription factor PPARalpha. Because PPARalpha regulates the oxidative degradation of fatty acids and their derivatives, like this lipid mediator, a feedback mechanism is proposed that controls the duration of an inflammatory response and the clearance of leukotriene B4 in the liver. Thus PPARalpha offers a new route to the development of anti- or pro-inflammatory reagents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FFAs act as PPAR agonists facilitating translocation to the nucleus and dimerization to RXR [77,78].”
From Lipoprotein Lipase Regulates Microglial Lipid Droplet Accumulation (2021) · cites this paper as [77]
In the citing paper
“PPAR-α is involved in the regulation of pro-inflammatory genes, mainly by limiting cytokine expression.[109]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [109]
Citations
Cites
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Self-citationKliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A., & Evans, R. M. (1992) · Nature · doi:10.1038/358771a0 · Cited by 1,741
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Self-citationKliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992) · Cell · doi:10.1016/0092-8674(92)90031-7 · Cited by 1,376
Self-citation
Research works printed but not linked: 6
- Ford-Hutchinson, A. W. Crit. Rev. Immunol. 10, 1–11 (1990).
- Desvergne, B. & Wahli, W. in Inducible Transcription Vol. 1 (ed. Bæuerle, P.) 142–176 (Birkhäuser, Boston, 1995).
- Greene, M. E. et al. Gene Expr. 4, 281–299 (1995).
- Schmidt, A. et al. Mol. Endocrinol. 6, 1634–1641 (1992).
- Yu, K. et al. J. Biol. Chem. 270, 23975–23983 (1995). · DOI · Paper page
- Peters, J. M. et al. Mol. Pharmacol. 50, 67–94 (1996).
Cited by
Items 201–300 of 1,001
Enzymes involved in jasmonic acid biosynthesis
Mueller, M. J. (1997) · Physiologia Plantarum · doi:10.1034/j.1399-3054.1997.1000329.x · Cited by 178
Fenofibrate Simultaneously Induces Hepatic Fatty Acid Oxidation, Synthesis, and Elongation in Mice
Oosterveer, M. H., Grefhorst, A., van Dijk, T. H., Havinga, R., Staels, B., Kuipers, F., Groen, A. K., & Reijngoud, D.-J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.051052 · Cited by 174
Role of PPARα in mediating the effects of phthalates and metabolites in the liver
Lapinskas, P. J., Brown, S., Leesnitzer, L. M., Blanchard, S., Swanson, C., Cattley, R. C., & Corton, J. C. (2005) · Toxicology · doi:10.1016/j.tox.2004.09.008 · Cited by 173
Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes
Blaschke, F., Takata, Y., Caglayan, E., Law, R. E., & Hsueh, W. A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000191663.12164.77 · Cited by 176
Devchand, P. R., Arita, M., Hong, S., Bannenberg, G., Moussignac, R., Gronert, K., & Serhan, C. N. (2003) · The FASEB Journal · doi:10.1096/fj.02-0770com · Cited by 176
“The functional evaluation of eicosanoid pathways in vivo has involved the use of genetically engineered mouse models, including targeted disruption at several stages of the signaling cascades ranging from biosynthetic enzymes (6, 7), to cell surface (8, 9) and nuclear ( 10 ) receptors.”
BackgroundSelf-citationSheu, M. Y., Fowler, A. J., Kao, J., Schmuth, M., Fluhr, J. W., Man, M.-Q., Elias, P. M., Feingold, K. R., Schoonjans, K., & Auwerx, J. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01626.x · Cited by 177
Molecular Recognition of Agonist Ligands by RXRs
Egea, P. F. (2002) · Molecular Endocrinology · doi:10.1210/me.16.5.987 · Cited by 173
Cyclooxygenase‐2 modulates cellular growth and promotes tumorigenesis
Trifan, O. C., & Hla, T. (2003) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2003.tb00222.x · Cited by 176
Haribabu, B., Verghese, M. W., Steeber, D. A., Sellars, D. D., Bock, C. B., & Snyderman, R. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.433 · Cited by 175
“Nonenzymatic formation of LTB 4 receptor agonists have been demonstrated (17), and the nuclear receptor peroxisome proliferator-activated receptor α was shown to mediate several of the effects of LTB 4 ( 18 ).”
BackgroundEllinghaus, P., Wolfrum, C., Assmann, G., Spener, F., & Seedorf, U. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2766 · Cited by 170
Yu, J., Ip, E., dela Peña, A., Hou, J. Y., Sesha, J., Pera, N., Hall, P., Kirsch, R., Leclercq, I., & Farrell, G. C. (2006) · Hepatology · doi:10.1002/hep.21108 · Cited by 169
Hanley, K., Jiang, Y., Crumrine, D., Bass, N. M., Appel, R., Elias, P. M., Williams, M. L., & Feingold, K. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119583 · Cited by 171
The role of fibric acids in atherosclerosis
Fruchart, J.-C., Staels, B., & Duriez, P. (2001) · Current Atherosclerosis Reports · doi:10.1007/s11883-001-0015-x · Cited by 170
Flavell, D. M., Torra, I. P., Jamshidi, Y., Evans, D., Diamond, J. R., Elkeles, R. S., Bujac, S. R., Miller, G., Talmud, P. J., Staels, B., et al. (2000) · Diabetologia · doi:10.1007/s001250051357 · Cited by 171
The role of leukotrienes in allergic diseases
Liu, M., & Yokomizo, T. (2015) · Allergology International · doi:10.1016/j.alit.2014.09.001 · Cited by 162
Systemic Linoleic and γ-Linolenic Acid Therapy in Dry Eye Syndrome With an Inflammatory Component
Barabino, S., Rolando, M., Camicione, P., Ravera, G., Zanardi, S., Giuffrida, S., & Calabria, G. (2003) · Cornea · doi:10.1097/00003226-200303000-00002 · Cited by 170
Imai, H., Narashima, K., Arai, M., Sakamoto, H., Chiba, N., & Nakagawa, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.1990 · Cited by 169
Asati, V., Mahapatra, D. K., & Bharti, S. K. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.025 · Cited by 165
Jonkers, I. J., Mohrschladt, M. F., Westendorp, R. G., van der Laarse, A., & Smelt, A. H. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01123-8 · Cited by 166
CLARKE, S. D., GASPERIKOVA, D., NELSON, C., LAPILLONNE, A., & HEIRD, W. C. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04284.x · Cited by 167
Gizard, F., Amant, C., Barbier, O., Bellosta, S., Robillard, R., Percevault, F., Sevestre, H., Krimpenfort, P., Corsini, A., Rochette, J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22756 · Cited by 160
Derosa, G., Sahebkar, A., & Maffioli, P. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25804 · Cited by 165
“PPAR-α is activated by eicosanoids derived from arachidonic acid metabolism including 8-Shydroxyeicosatetraenoic acid (8SHETE) and leukotriene B4 (LTB4) (Devchand et al., 1996; Forman, Chen, & Evans, 1997; Kliewer et al., 1997).”
MethodMitochondrial protein acetylation is driven by acetyl-CoA from fatty acid oxidation
Pougovkina, O., te Brinke, H., Ofman, R., van Cruchten, A. G., Kulik, W., Wanders, R. J. A., Houten, S. M., & de Boer, V. C. J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu059 · Cited by 163
The organization and consequences of eicosanoid signaling
Soberman, R. J., & Christmas, P. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18338 · Cited by 162
Ogata, T., Miyauchi, T., Sakai, S., Takanashi, M., Irukayama-Tomobe, Y., & Yamaguchi, I. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.043 · Cited by 165
Rivier, M., Safonova, I., Lebrun, P., Michel, S., Griffiths, C. E. M., & Ailhaud, G. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00439.x · Cited by 162
Dyslipidemia and cardiovascular risk: the importance of early prevention
Miller, M. J. (2009) · QJM · doi:10.1093/qjmed/hcp065 · Cited by 195
Ricote, M., Valledor, A. F., & Glass, C. K. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000103951.67680.b1 · Cited by 162
Zambon, A., Gervois, P., Pauletto, P., Fruchart, J.-C., & Staels, B. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000204327.96431.9a · Cited by 162
Cytochrome P450 Eicosanoids are Activators of Peroxisome Proliferator-Activated Receptor α
Ng, V. Y., Huang, Y., Reddy, L. M., Falck, J. R., Lin, E. T., & Kroetz, D. L. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.013839 · Cited by 158
“Other related eicosanoids such as prostacyclin, some prostaglandins, and leukotriene B4 also activate PPAR (Devchand et al., 1996).”
BackgroundPhysiological functions of peroxisome proliferator-activated receptor β
Neels, J. G., & Grimaldi, P. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00027.2013 · Cited by 161
Bäck, M., Dahlén, S., Drazen, J. M., Evans, J. F., Serhan, C. N., Shimizu, T., Yokomizo, T., & Rovati, G. E. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.004184 · Cited by 170
Towards the Construction of Climate Change Scenarios
Mitchell, J. F. B., Johns, T. C., Eagles, M., Ingram, W. J., & Davis, R. A. (1999) · Climatic Change · doi:10.1023/a:1005466909820 · Cited by 160
Zomer, A. W. M., van der Burg, B., Jansen, G. A., Wanders, R. J. A., Poll-The, B. T., & van der Saag, P. T. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31973-8 · Cited by 157
Chen, X. (2001) · Carcinogenesis · doi:10.1093/carcin/22.8.1119 · Cited by 161
Faveeuw, C., Fougeray, S., Angeli, V., Fontaine, J., Chinetti, G., Gosset, P., Delerive, P., Maliszewski, C., Capron, M., Staels, B., et al. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02319-x · Cited by 158
Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney
Yang, T., Michele, D. E., Park, J., Smart, A. M., Lin, Z., Brosius, F. C., Schnermann, J. B., & Briggs, J. P. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.6.f966 · Cited by 162
Liang, D., Moutinho, J. L., Golan, R., Yu, T., Ladva, C. N., Niedzwiecki, M., Walker, D. I., Sarnat, S. E., Chang, H. H., Greenwald, R., et al. (2018) · Environment International · doi:10.1016/j.envint.2018.07.044 · Cited by 158
“…A4 (LTA4) hydrolase from LTA4, is a potent chemoattractant and proinflammatory mediator that recruits cells from the immune system to produce inflammation and induces the release of lysosomal enzymes by neutrophils (Cotran et al., 1999; Devchand et al., 1996; Ford-Hutchinson et al., 1980).”
Holdsworth‐Carson, S. J., Lim, R., Mitton, A., Whitehead, C. L., Rice, G. E., Permezel, M., & Lappas, M. (2010) · Placenta · doi:10.1016/j.placenta.2009.12.009 · Cited by 169
Gervois, P., Vu-Dac, N., Kleemann, R., Kockx, M., Dubois, G., Laine, B., Kosykh, V., Fruchart, J.-C., Kooistra, T., & Staels, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102839200 · Cited by 153
Fournier, T., Tsatsaris, V., Handschuh, K., & Evain‐Brion, D. (2006) · Placenta · doi:10.1016/j.placenta.2006.04.009 · Cited by 172
Oxidative Stress and Transcriptional Regulation in Alzheimer Disease
Shi, Q., & Gibson, G. E. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815721c3 · Cited by 157
Exosomes Mediate LTB4 Release during Neutrophil Chemotaxis
Majumdar, R., Tavakoli Tameh, A., & Parent, C. A. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002336 · Cited by 152
RetractedGervois, P., Chopin-Delannoy, S., Fadel, A., Dubois, G., Kosykh, V., Fruchart, J.-C., Najïb, J., Laudet, V., & Staels, B. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.3.0248 · Cited by 142
Peters, J. M., Park, Y., Gonzalez, F. J., & Pariza, M. W. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(01)00155-x · Cited by 158
Self-citationJahoor, A., Patel, R., Bryan, A., Do, C., Krier, J., Watters, C., Wahli, W., Li, G., Williams, S. C., & Rumbaugh, K. P. (2008) · Journal of Bacteriology · doi:10.1128/jb.01444-07 · Cited by 172
“For example, the peroxisome proliferator-activated receptors (PPARs) are a subset of NHRs with documented anti-inflammatory effects ( 15 , 25, 48), and several 3OC12-HSL-activated genes are also PPAR targets (24).”
BackgroundSelf-citationMinireview: A Novel Pathway of Prostacyclin Signaling—Hanging Out with Nuclear Receptors
Lim, H. J., & Dey, S. K. (2002) · Endocrinology · doi:10.1210/en.2002-220159 · Cited by 170
Huang, W., García-Zepeda, E. A., Sauty, A., Oettgen, H. C., Rothenberg, M. E., & Luster, A. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1063 · Cited by 169
PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
Ahmed, W., Ziouzenkova, O., Brown, J., Devchand, P., Francis, S., Kadakia, M., Kanda, T., Orasanu, G., Sharlach, M., Zandbergen, F., et al. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01825.x · Cited by 153
Self-citationShappell, S. B., Boeglin, W. E., Olson, S. J., Kasper, S., & BRASH, A. R. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65117-6 · Cited by 161
Structural Elements of an Orphan Nuclear Receptor–DNA Complex
Zhao, Q., Khorasanizadeh, S., Miyoshi, Y., Lazar, M. A., & Rastinejad, F. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80084-2 · Cited by 147
Khan, S. A., & Heuvel, J. P. V. (2003) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(03)00098-6 · Cited by 180
In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs)
Corsini, E., Avogadro, A., Galbiati, V., Dell’Agli, M., Marinovich, M., Galli, C. L., & Germolec, D. R. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.11.004 · Cited by 156
Moya-Camarena, S. Y., Heuvel, J. P. V., & Belury, M. A. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s0005-2760(98)00121-0 · Cited by 152
PPAR-α Activation Mediates Innate Host Defense through Induction of TFEB and Lipid Catabolism
Kim, Y. S., Lee, H.-M., Kim, J. K., Yang, C.-S., Kim, T. S., Jung, M., Jin, H. S., Kim, S., Jang, J., Oh, G. T., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601920 · Cited by 151
Fougerat, A., Montagner, A., Loiseau, N., Guillou, H., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071638 · Cited by 157
Self-citationGervois, P., Torra, I. P., Chinetti, G., Grötzinger, T., Dubois, G., Fruchart, J.-C., Fruchart-Najib, J., Leitersdorf, E., & Staels, B. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.9.0341 · Cited by 140
Trifilieff, A., Bench, A., Hanley, M., Bayley, D., Campbell, E., & Whittaker, P. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705232 · Cited by 148
“In vivo, inflammation induced by LTB4, a PPAR-a ligand, was shown to be prolonged in PPAR-a-deficient mice (Devchand et al., 1996), suggesting an anti-inflammatory role for this receptor.”
BackgroundD’Agostino, G., Russo, R., Avagliano, C., Cristiano, C., Meli, R., & Calignano, A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.25 · Cited by 164
Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity
Régnier, M., Polizzi, A., Smati, S., Lukowicz, C., Fougerat, A., Lippi, Y., Fouché, E., Lasserre, F., Naylies, C., Bétoulières, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63579-3 · Cited by 140
Self-citationThe roles of PPARs in adipocyte differentiation
Grimaldi, P. A. (2001) · Progress in Lipid Research · doi:10.1016/s0163-7827(01)00005-4 · Cited by 163
SHIROSHITATAKESHITA, A., BRUNDEL, B., BURSTEIN, B., LEUNG, T., MITAMURA, H., OGAWA, S., & NATTEL, S. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.01.002 · Cited by 149
“We elected to compare simvastatin to fenofibrate because both are lipid-lowering drugs and PPAR-αagonists like fenofibrate also have pleiotropic antiinflammation and antiproliferative effects [ 13 ,14] .O ur results showthatdespitesomesimilarities,statinsandPPAR-αagonists have very different efficacy in preventing CHF…”
BackgroundAbuse of anabolic‐androgenic steroids and bodybuilding acne: an underestimated health problem
Melnik, B., Jansen, T., & Grabbe, S. (2007) · JDDG: Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2007.06176.x · Cited by 147
Gambino, R., Musso, G., & Cassader, M. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.3058 · Cited by 147
Genome-wide analysis of PPARα activation in murine small intestine
Bünger, M., van den Bosch, H. M., van der Meijde, J., Kersten, S., Hooiveld, G. J. E. J., & Müller, M. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00198.2006 · Cited by 144
From Surface to Nuclear Receptors: The Endocannabinoid Family Extends its Assets
Pistis, M., & Melis, M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980014 · Cited by 142
Activation of the Ah Receptor Signaling Pathway by Prostaglandins
Seidel, S. D., Winters, G. M., Rogers, W. J., Ziccardi, M. H., Li, V., Keser, B., & Denison, M. S. (2001) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.16 · Cited by 142
Effects of peroxisome proliferators on the thymus and spleen of mice
Yang, Q., Xie, Y., & Depierre, J. W. (2008) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2000.01367.x · Cited by 143
Vu-Dac, N., Gervois, P., Torra, I. P., Fruchart, J. C., Kosykh, V, Kooistra, T., Princen, H. M., Dallongeville, J., & Staels, B. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1581 · Cited by 143
Accelerated Diabetic Nephropathy in Mice Lacking the Peroxisome Proliferator–Activated Receptor α
Park, C. W., Kim, H. W., Ko, S. H., Chung, H. W., Lim, S. W., Yang, C. W., Chang, Y. S., Sugawara, A., Guan, Y., & Breyer, M. D. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1329 · Cited by 144
“Because PPAR enhances the activity of the -oxidation pathway, the consequent degradation of arachidonic acid and leukotrienes directly results in the termination of inflammation (24).”
BackgroundRegulatory potential of n-3 fatty acids in immunological and inflammatory processes
Grimm, H., Mayer, K., Mayser, P., & Eigenbrodt, E. (2002) · British Journal of Nutrition · doi:10.1079/bjn2001457 · Cited by 143
“Peroxisome proliferator-activated receptors (PPAR) are a group of key nuclear receptors involved in lipid homeostasis (Forman et al. 1997; Kliewer et al. 1997; Devchand et al. 1996), which have been also identified in lymphoid tissue (Braissant et al. 1996).”
BackgroundFruchart, J.-C., Santos, R. D., Aguilar-Salinas, C., Aikawa, M., Al Rasadi, K., Amarenco, P., Barter, P. J., Ceska, R., Corsini, A., Després, J.-P., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0864-7 · Cited by 140
Self-citationFatty acids and the immune system: from basic science to clinical applications
Yaqoob, P. (2004) · Proceedings of the Nutrition Society · doi:10.1079/pns2003328 · Cited by 139
“…and PPAR-a ligands have been demonstrated to inhibit phorbol esterstimulated cytokine production by monocytic cells (Jiang et al. 1998) and studies using PPAR-a knock-out mice have demonstrated prolonged inflammatory responses (Devchand et al. 1996), suggesting that PPAR may be anti-inflammatory.”
BackgroundKockx, M., Gervois, P. P., Poulain, P., Derudas, B., Peters, J. M., Gonzalez, F. J., Princen, H. M. G., Kooistra, T., & Staels, B. (1999) · Blood · doi:10.1182/blood.v93.9.2991 · Cited by 139
Self-citationD’Agostino, G., La Rana, G., Russo, R., Sasso, O., Iacono, A., Esposito, E., Raso, G. M., Cuzzocrea, S., Lo Verme, J., Piomelli, D., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123265 · Cited by 138
“Moreover, mutant mice lacking PPAR- (PPAR- / ) showed a prolonged inflammatory response when challenged with leukotriene B4 or arachidonic acid (Devchand et al., 1996).”
BackgroundHan, C. Y., Chiba, T., Campbell, J. S., Fausto, N., Chaisson, M., Orasanu, G., Plutzky, J., & Chait, A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000227472.70734.ad · Cited by 140
PPARγ activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes
Martin, G., Schoonjans, K., Staels, B., & Auwerx, J. H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00315-8 · Cited by 160
Dowell, P., Ishmael, J. E., Avram, D., Peterson, V. J., Nevrivy, D. J., & Leid, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15901 · Cited by 136
Hellemans, K., Michalik, L., Dittie, A., Knorr, A., Rombouts, K., de Jong, J., Heirman, C., Quartier, E., Schuit, F., Wahli, W., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50015 · Cited by 137
Self-citationFatehi-Hassanabad, Z., & Chan, C. B. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-1 · Cited by 135
D'Agostino, G., La Rana, G., Russo, R., Sasso, O., Iacono, A., Esposito, E., Mattace Raso, G., Cuzzocrea, S., LoVerme, J., Piomelli, D., et al. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.04.022 · Cited by 135
“Both PPAR-α and PPAR-gamma receptor subtypes regulate in vivo and in vitro inflammatory responses (Devchand et al., 1996; Delerive et al., 2001; Kostadinova et al., 2005).”
BackgroundSertznig, P., Seifert, M., Tilgen, W., & Reichrath, J. (2008) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200809010-00002 · Cited by 150
Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands
Kohno, H., Suzuki, R., Sugie, S., & Tanaka, T. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-46 · Cited by 142
5-Lipoxygenase Reaction Products Modulate Alveolar Macrophage Phagocytosis ofKlebsiella pneumoniae
Mancuso, P., Standiford, T. J., Marshall, T. M., & Peters-Golden, M. L. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5140-5146.1998 · Cited by 153
Bordji, K., Grillasca, J.-P., Gouze, J.-N., Magdalou, J., Schohn, H., Keller, J.-M., Bianchi, A., Dauça, M., Netter, P., & Terlain, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12243 · Cited by 134
Flavell, D. M., Jamshidi, Y., Hawe, E., Pineda Torra, I., Taskinen, M.-R., Frick, M. H., Nieminen, M. S., Kesäniemi, Y. A., Pasternack, A., Staels, B., et al. (2002) · Circulation · doi:10.1161/01.cir.0000012145.80593.25 · Cited by 134
Treatment of asthma with antileukotrienes: First line or last resort therapy?
Dahlén, S. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.070 · Cited by 133
Fish oil emulsions: what benefits can they bring?
Fürst, P., & Kuhn, K. (2000) · Clinical Nutrition · doi:10.1054/clnu.1999.0072 · Cited by 133
Leuenberger, N., Pradervand, S., & Wahli, W. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39019 · Cited by 128
Self-citationNew insights into the role of COX 2 in inflammation
Gilroy, D. W., & Colville‐Nash, P. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000094 · Cited by 144
“While this is predominantly a leukotriene-mediated reaction, these authors went on to show that leukotriene B 4 itself is a ligand for PPARα [ 63 ].”
BackgroundKintscher, U., Goetze, S., Wakino, S., Kim, S., Nagpal, S., Chandraratna, R. A. S., Graf, K., Fleck, E., Hsueh, W. A., & Law, R. E. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00461-1 · Cited by 146
Yang, Q., Xie, Y., Alexson, S. E. H., Dean Nelson, B., & DePierre, J. W. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00923-1 · Cited by 131
Robinson, E., & Grieve, D. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.003 · Cited by 138
Bishop‐Bailey, D., & Wray, J. A. (2003) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(03)00003-0 · Cited by 151
Zhou, Y.-C., & Waxman, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2672 · Cited by 131
Basu-Modak, S., Braissant, O., Escher, P., Desvergne, B., Honegger, P., & Wahli, W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35881 · Cited by 130
Self-citationInvolvement of leukotriene B4 in arthritis models
Tsuji, F., Oki, K., Fujisawa, K., Okahara, A., Horiuchi, M., & Mita, S. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00556-6 · Cited by 130
Belury, M. A., Moya-Camarena, S. Y., Liu, K.-L., & Heuvel, J. P. V. (1997) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(97)00093-4 · Cited by 145
Is Acne vulgaris a Genuine Inflammatory Disease?
Zouboulis, C. C. (2001) · Dermatology · doi:10.1159/000051771 · Cited by 130
Ramanan, S., Kooshki, M., Zhao, W., Hsu, F.-C., Riddle, D. R., & Robbins, M. E. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.06.059 · Cited by 126
Metadata
- Authors
- Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W.
- Affiliations
- University of Lausanne (CH)
- National Institutes of Health (US)
- Venue
- Nature
- Published
- 1996-11
- Volume
- 384
- Issue
- 6604
- Pages
- 39-43
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1671834350
- Cited by
- 1,345
- References
- 43
- Citations by year
- 2026: 3 · 2025: 17 · 2024: 14 · 2023: 21 · 2022: 9 · 2021: 38 · 2020: 30 · 2019: 23 · 2018: 21 · 2017: 24 · 2016: 23 · 2015: 22 · 2014: 43 · 2013: 34 · 2012: 49
- FWCI
- 28.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- PPARα, leukotriene B4, inflammation, transcription factor activation, fatty acid oxidation, lipid mediators, chemotaxis, anti-inflammatory agents, liver, feedback regulation
- MeSH terms
- Adaptation, Physiological, Animals, Cells, Cultured, Fatty Acids, Female, Gene Expression Regulation, HeLa Cells, Humans, Inflammation, Leukotriene B4, Ligands, Liver, Male, Oxidation-Reduction, Plasmids, Pyrimidines, Time Factors, Transcription Factors, Transfection, Chloramphenicol O-Acetyltransferase, Arachidonic Acid, Rats, Sprague-Dawley, Receptors, Cytoplasmic and Nuclear, Inflammation Mediators, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.